Italie - italien - AIFA (Agenzia Italiana del Farmaco)

eg s.p.a. - atazanavir - atazanavir

Union européenne - italien - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cobicistat, atazanavir - infezioni da hiv - antivirali per uso sistemico - evotaz is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1 infected adults and adolescents (aged 12 years and older weighing at least 35 kg) without known mutations associated with resistance to atazanavir (see sections 4. 4 e 5.

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - atazanavirum - capsule - atazanavirum 100 mg a atazanaviri sulfas, colore.: e 132, excipiens pro capsula. - le infezioni da hiv - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - atazanavirum - capsule - atazanavirum 150 mg per atazanaviri sulfas, colore.: e 132, excipiens pro capsula. - le infezioni da hiv - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - atazanavirum - capsule - atazanavirum 200 mg per atazanaviri sulfas, colore.: e 132, excipiens pro capsula. - le infezioni da hiv - synthetika

Suisse - italien - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - atazanavirum - capsule - atazanavirum 300 mg per atazanaviri sulfas, colore.: e 132, excipiens pro capsula. - le infezioni da hiv - synthetika

Union européenne - italien - EMA (European Medicines Agency)

les laboratoires servier - irinotecan anhydrous free-base - neoplasie pancreatiche - agenti antineoplastici - trattamento di adenocarcinoma metastatico del pancreas, in associazione con 5 fluorouracile (5 fu) e leucovorin (lv), in pazienti adulti che hanno progredito in seguito alla terapia con gemcitabina.